RxDoctor Payments Data

Leah Amorose

Family · Taylor, MINPI 1073172326

Payments from drug & device makers

$2,461in general payments, 2019–2025

Across 132 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$718
  • Boehringer Ingelheim$256
  • Novo Nordisk$205
  • Lilly USA, LLC$184
  • Pfizer$176
  • Exact Sciences$167
  • plus $755 from 14 others

What the payments were for

  • Food & beverage$2,461100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,461 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban45$50,970
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$42,929
Breztri AerosphereBudesonide/Glycopyr/Formoterol37$42,167
ZenpepLipase/Protease/Amylase14$41,620
FarxigaDapagliflozin Propanediol36$34,055
MounjaroTirzepatide25$25,402
RybelsusSemaglutide19$25,302
JardianceEmpagliflozin25$24,479
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog19$18,613
Bevespi AerosphereGlycopyrrolate/Formoterol Fum20$16,541
JanuviaSitagliptin Phosphate12$15,989
Spiriva RespimatTiotropium Bromide25$14,687
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$14,132
OzempicSemaglutide13$14,044
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$11,024

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga, Bevespi Aerosphere$718$92,76393 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta$93$59,48756 claims
PfizerEliquis$176$50,97045 claims
Aimmune Therapeutics, Inc.Zenpep$73$41,62014 claims
Novo NordiskRybelsus, Ozempic$205$39,34532 claims
Boehringer IngelheimJardiance, Spiriva Respimat$256$39,16550 claims
Lilly USA, LLCMounjaro$184$25,40225 claims
Indivior Inc.Suboxone$42$4,97816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,657 family providers in Michigan.

Other family in Taylor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →